2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
-
PatentDataCmpdsUniProt
HGNC*Patent TitleOrganizationDepositionDownloads -
17DIMERIC COMPOUNDS AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOFMaze Therapeutics08/19/26
-
409NOVEL DERIVATIVES HAVING 2,3-DIHYDRO-1H-INDENE OR 2,3-DIHYDROBENZOFURAN MOIETY OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAMEYuhan08/19/26
-
1SOLID FORMS OF COMPOUND I OR SALTS THEREOFJacobio Pharmaceuticals Co.08/19/26
-
2POLYCYCLIC COMPOUND AND USE THEREOFHainan Simcere Zaiming Pharmeceutical Co.08/19/26
-
29TRICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF TYK2 AND/OR JAK1Incyte08/19/26
-
53MACROCYCLIC CFTR MODULATORSIdorsia Pharmaceuticals08/19/26
-
5Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseasesShanghai East Hospital08/17/26
-
25Macrocyclic ULK1/2 inhibitorsSalk Institute08/17/26
-
38Pyrimidine-2,4-diamine compound and preparation method and application thereofAnhui Medical University08/17/26
-
32Preparation method for amide compound and application thereof in field of medicineShanghai Synergy Pharmaceutical Sciences Co.08/17/26
-
194METHODS OF TREATING INFLAMMATORY DISEASESInterline Therapeutics08/12/26
-
29DUAL INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASEUniversitat De Barcelona08/12/26
-
57Aromatic Acetylene Derivative, Preparation Method Therefor, And Pharmaceutical Use ThereofZhejiang Hisun Pharmaceutical Co.08/12/26
-
371Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use ThereofGuangzhou Vinnocent Pharmaceutical08/12/26
-
30Adamantane derivatives as inhibitors of focal adhesion kinaseSamjin Pharmaceutical Co.08/10/26
-
35Inhibiting USP36Valo Health08/10/26
-
6Antiviral agents and uses thereofGriffith University08/10/26
-
41Salt and crystal form of steroid derivative regulatorShanghai Hansoh Biomedical Co.08/10/26
-
393POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINSAvilar Therapeutics08/05/26
-
73N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOFMaze Therapeutics08/05/26
-
56Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase InhibitionTaiwanj Pharmaceuticals Co.08/05/26
-
17TRIPLE KINASE INHIBITORSUnogen Biotech08/05/26
-
135BENZOFURAN DERIVATIVES AS SIK INHIBITORS AND THE USE THEREOFBeone Medicines I08/05/26
-
208NOVEL COMPOUNDS AS CK2 INHIBITORSCambridge Enterprise08/05/26
-
88BENZAMIDE COMPOUNDS AND METHODS OF USE THEREOFThe State University of New Jersey08/05/26
-
1PRODRUGSCambridge Enterprise08/05/26
-
4HETEROCYCLIC CBL-B INHIBITORS FOR THE TREATMENT OF CANCERHotspot Therapeutics08/05/26
-
262PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPYHotspot Therapeutics08/05/26
-
2CRYSTAL FORM OF AROMATIC HETEROCYCLIC COMPOUND, COMPOSITION THEREOF, PRODUCTION METHOD THEREOF AND USES THEREOFHangzhou Yuhong Pharmaceutical Technology Co.08/05/26
-
21IRAK4 kinase inhibitor and preparation method thereforGuangzhou Yufan Nantu Biotechnologies Co.08/03/26
-
10Method for treating idiopathic pulmonary fibrosisBeijing Tide Pharmaceutical Co.08/03/26
-
84Cyano-substituted pyridine and cyano-substituted pyrimidine compound and preparation method therefor and application thereofBeijing Scitech-MQ Pharmaceuticals08/03/26
-
2Methods of treating disorders using CSFIR inhibitorsDeciphera Pharmaceuticals08/03/26
-
71Broad spectrum antivirals against coronavirusKansas State University Research Foundation; Wichita State University; University of Iowa Research Foundation08/03/26
-
116Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancerRedona Therapeutics08/03/26
-
319Sulphonamide compoundsAnaxis Pharma08/03/26
-
13Tetrahydropyrrolocyclic compound and application thereofBreakthrough Pharmaceuticals08/03/26
-
51H-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseasesNewave Pharmaceutical08/03/26
-
77RET selective inhibitor, preparation method therefor and use thereofShouyao Holdings (Beijing) Co.08/03/26
-
94Inhibitors of protein kinase ABlueprint Medicines08/03/26
-
62TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASESShanghai Raising Pharmaceutical Co.07/29/26
-
19NEUROTENSIN RECEPTOR LIGANDS3B Pharmaceuticals07/29/26
-
73COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOFTyk Medicines07/29/26
-
9INHIBITORS OF ENL/AF9 YEATS AND FLT3Bridge Medicines07/29/26
-
186INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORSHoffmann-La Roche07/29/26
-
3PYRAZOLO[1,5-A]PYRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOFShanghai Daidai Investment Consulting Co.07/29/26
-
19JAK INHIBITOR AND PREPARATION METHOD THEREFORFelicamed Biotechnology Co.07/29/26
-
648NAMPT MODULATORS, PREPARATIONS, AND USES THEREOFSironax07/29/26
-
61615-PGDH inhibitorKyorin Pharmaceutical Co.07/27/26
-
212-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)- acetamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5Agomab Spain S.L.U.07/27/26
-
1Crystalline form of CXCR2 antagonist and application thereofShenzhen Optimum Biological Technology Co.07/27/26
-
77Substituted [1,2,4]triazolo[1,5-a]pyrazines as spleen tyrosine kinase inhibitorsNanjing Ruijie Pharma Co.07/27/26
-
2689Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitorsRelay Therapeutics07/27/26
-
14P11309 Q86V86 Q9HAZ1 P49761 P49760 Q9P1W9 P49759 P36888
HGNC:2068 13659 2069 19310 2071 8986 3765 8987INDAZOLE MACROCYCLES AND THEIR USEBlossomhill Therapeutics07/23/26 -
47INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASEHoffmann-La Roche07/23/26
-
95DDR1 AND DDR2 INHIBITORS FOR THE TREATEMENT OF CANCER AND FIBROTIC DISEASESRedx Pharma07/22/26
-
88TNKS2 INHIBITORSCornell University07/22/26
-
2TRKA (G667C) AND FLT3 TARGET INHIBITOR AND COMBINATION OF SAME WITH CHIDAMIDEShenzhen Chipscreen Biosciences07/22/26
-
135AMIDE OR UREA COMPOUNDShenzhen Zhongge Biological Technology07/22/26
-
107-ALKOXYQUINOLINES AS MODULATORS OF POLRMTPretzel Therapeutics07/22/26
-
174NOVEL COMPOUNDS AS CK2 INHIBITORSCambridge Enterprise07/22/26
-
217SUBSTITUTED PYRROLO[2,1-F][1,2,4]TRIAZIN-2-AMINES AS CDK2 AND CDK4 INHIBITORSIncyte07/22/26
-
44SUBSTITUTED 7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINES AS SELECTIVE CDK2/4 INHIBITORSIncyte07/22/26
-
11HETEROBICYCLIC COMPOUNDS AS EP4 RECEPTOR ANTAGONISTSShenzhen Ionova Life Science07/22/26
-
356,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancerLes Laboratoires Servier07/21/26
-
19Compound as cyclin-dependent kinase 9 inhibitor and use thereofCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)07/20/26
-
44Phenyl amino pyrimidine compounds and uses thereofGlaxosmith Kline07/20/26
-
41Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of BtkBiogen Ma07/20/26
-
37Compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameChong Kun Dang Pharmaceutical07/20/26
-
160Bicyclic heteroaryl compounds useful as IRAK4 inhibitorsBristol Myers Squibb07/20/26
-
6c-Myc protein inhibitor, and preparation method therefor and use thereofSuzhou Kintor Pharmaceuticals07/20/26
-
323Boronic acid compoundsLG Chem07/20/26
-
41SUBSTITUTED HETEROCYCLES AS RAS INHIBITORSJazz Pharmaceuticals Ireland07/15/26
-
32SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORSResearch Triangle Institute07/15/26
-
190SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAMEMitsubishi Tanabe Pharma07/15/26
-
437NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING MYT1 INHIBITORY ACTIVITYChugai Seiyaku Kabushiki Kaisha07/15/26
-
87NOVEL DPP1 INHIBITORS AND USES THEREOFInsmed07/15/26
-
42,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitorsRevolution Medicines07/13/26
-
5Thiophene derivatives as xanthine oxidase inhibitors and application thereofTonghua Dongbao Pharmaceutical07/13/26
-
16,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RETGuangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory07/13/26
-
161Anaplastic Lymphoma Kinase (ALK) degraders and uses thereofTriana Biomedicines07/13/26
-
33VMAT2 inhibitor and preparation method therefor and application thereofLuye Innomind Pharma Shijiazhuang07/13/26
-
120Sulfone derivativesHoffmann-La Roche07/13/26
-
4Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitorsBiogen Ma07/13/26
-
31P50750 A0A090N7W4 P50613 P30285 P20248 Q00535 Q00534 P30281 O60563 P24941 P24864 P06493 Q00526 P25322 Q15078
HGNC:3785 1771 1778 1722 1777 1774 3767 1775Substituted 1′,2′-dihydro-3′h-spiro[cyclohexane-1,4′-pyrimido[5′,4′:4,5]pyrrolo[2,1-c] [1,2,4]triazin]-3′-ones as cyclin-dependent kinase inhibitorsPharmacosmos Holding07/13/26 -
100Spirocyclic O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitorsBiogen Ma07/13/26
-
24HETEROCYCLIC COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOFJiangsu Hengrui Pharmaceuticals Co.07/09/26
-
51NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOFInsmed07/09/26
-
115PYRIDO-PYRAZOLES AS INHIBITORS OF DDR'S FOR THE TREATMENT OF FIBROTIC DISORDERS AND CANCERRedx Pharma07/09/26
-
1A0A024R3T8 Q7Z3E1 Q9UGN5 Q9H2K2 Q460N5 O95271 Q460N3 Q2NL67 P09874
HGNC:29232 270 11941 272 15677 26921 23696 26876CRYSTAL FORM OF HETEROARYL DERIVATIVE PARP INHIBITOR AND USE THEREOFHaisco Pharmaceutical Group Co.07/09/26 -
6SERIES OF NITROGEN-CONTAINING BRIDGED HETEROCYCLIC COMPOUNDS AND PREPARATION METHOD THEREFORCMS Research & Development07/09/26
-
183TRIAZINE COMPOUNDS AND USES THEREOFHutchmed07/09/26
-
17HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCERHoffmann-La Roche07/09/26
-
87Bicyclic pyrimidinones as inhibitors of NOX4Boehringer Ingelheim International07/09/26
-
24SMALL MOLECULE COMPOUNDS WITH PHOSPHORYLATED ARYL STRUCTURES AND USE THEREOFHangzhou Phecdamed Co.07/09/26
-
3HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTIONDepartment Of Health & Human Services07/08/26
-
209PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORSAzkarra Therapeutics07/08/26
-
40Immunophilin binding agents and uses thereofUniversity Of California07/06/26
-
191,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereofJiangsu Nhwa Pharmaceutical Co.07/06/26
-
156Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPaseUniversity Of Pittsburgh07/06/26
-
27Crosslinked optically active secondary amine derivativeSumitomo Pharma Co.07/06/26
-
61Substituted Tetrazolyl Compounds Useful as T Cell ActivatorsBristol Myers Squibb07/01/26
-
110PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOFBeyang Therapeutics Co.07/01/26
-
59Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using SameBaylor College of Medicine07/01/26
-
31DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORSItalfarmaco07/01/26
-
3P10635 P11712 Q6GRK0 P20813 P33261 P08684 P10632 P05177 C1ID52
HGNC:2596 2637 2615 2625 2622 2623 2621AMIDO PYRIDO[3,4-B]INDOLE-1,4-DIONE COMPOUNDS FOR TREATMENT OF PORPHYRIASPortal Therapeutics07/01/26 -
92ENPP1 MODULATORS AND PRODUCTS AND USES THEREOFGossamer Bio Services07/01/26
-
6KRAS INHIBITOR COMPOUNDShanghai Apeiron Therapeutics Company07/01/26
-
95Inhibitors of MLH1 and/or PMS2 for cancer treatmentNeophore06/29/26
-
47Purine derivative and medical use thereofKangbaida (Sichuan) Biotechnology Co.06/29/26
-
22Pyrrolotriazine derivatives for treating kit-and PDGFRA-mediated diseasesBlueprint Medicines06/29/26
-
25Substituted imidazolecarboxamide as Bruton's tyrosine kinase inhibitorsHenan Zhiwei Biomedicine Co.06/29/26
-
32Triazolone compoundsNxera Pharma06/29/26
-
9Immunosuppressant, and preparation method therefor and use thereofAbbisko Therapeutics Co.06/29/26
-
153KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOFAlivexis06/26/26
-
10HETEROCYCLIC RING-SUBSTITUTED AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOFShanghai Henlius Biotech06/24/26
-
23P31645 P19327 P28335 P34969 P28222 P28223 P41595 P46098 P28221 Q86XA9 P50406
HGNC:5302 5301 5289 5287 5297 11050 5295 5294 5293 20276BENZYLTRYPTAMINE COMPOUNDSReunion Neuroscience06/24/26 -
161ANAPLASTIC LYMPHOMA KINASE (ALK) DEGRADERS AND USES THEREOFTriana Biomedicines06/24/26
-
234INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCERMerck Patent06/24/26
-
44Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of CancerNodus Oncology06/24/26
-
7FURO PYRIMIDINE DERIVATESMerck Patent06/24/26
-
104Bicyclic Ureas As Kinase InhibitorsIncyte06/24/26
-
371-aminosulfonyl-2-carboxypyrrole derivatives as metallo-beta-lactamase inhibitorsInfex Therapeutics06/22/26
-
76AZA-quinoline compounds and uses thereofNovartis06/22/26
-
1032, 4, 6-tri-substituted pyrimidine compound as ATR kinase inhibitorBeijing Tide Pharmaceutical06/22/26
-
3P52333 P29597 P10635 P11712 Q6GRK0 A0A024R7M7 P10632 C1ID52 O60674 P20813 P33261 P08684 P23458 P05177
HGNC:2596 6190 6192 6193 2637 2615 2625 12440 2622 2623 2621Crystalline forms of a TYK2 inhibitorSareum06/22/26 -
52Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivativesPfizer06/22/26
-
58Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereofDebiopharm International06/22/26
-
94Imidazopyridine derivative and pharmaceutical composition comprising same as active ingredientTSD Life Sciences06/22/26
-
515COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSISKojin Therapeutics06/18/26
-
52Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristicsThe Technical University of Darmstadt06/17/26
-
30THIADIAZOLONE DERIVATIVES, COMPOSITIONS AND USES THEREOFDanatlas Pharmaceuticals06/17/26
-
14NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAMEWashington University; Sage Therapeutics, Inc.06/17/26
-
29FIBROBLAST ACTIVATION PROTEIN-TARGETED COMPOSITIONS AND METHODS OF USE THEREOFRatio Therapeutics06/17/26
-
38INHIBITORS OF AKR1C3 AND METHODS OF USEUniversity of Nebraska06/17/26
-
139FTO INHIBITORSRpxds06/17/26
-
123,4-alkoxy Substituted Phenethyl Lactam Compound, Preparation Method therefor, and Use ThereofGuangzhou Chia Tai Innovative Pharmaceutical06/17/26
-
1521H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCERBayer Aktiengesellschaft; The Broad Institute, Inc.; Dana-Farber Cancer Institute, Inc.06/17/26
-
295COMPOUNDS AS SUMO ACTIVATING ENZYME INHIBITORSWigen Biomedicine Technology (Shanghai)06/17/26
-
456N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMerck Sharp & Dohme06/15/26
-
132Inhibitors of adrenoreceptor ADRAC2Bayer Aktiengesellschaft06/15/26
-
812TYROSINE KINASE 2 INHIBITORS AND USES THEREOFBiogen Ma06/12/26
-
43PHD INHIBITORSOxford University Innovation06/10/26
-
47A0A024R3T8 Q7Z3E1 Q9UGN5 Q9H2K2 Q460N5 O95271 Q460N3 Q2NL67 P09874
HGNC:29232 270 11941 272 15677 26921 23696 26876PHARMACEUTICAL COMPOSITION OF HETEROARYL DERIVATIVE AND MEDICAL USE THEREOFHaisco Pharmaceutical Group06/10/26 -
241,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND USES THEREOFChong Kun Dang Pharmaceutical06/10/26
-
282COMPOUND BASED ON ISOINDOLINE-SUBSTITUTED GLUTARIMIDE BACKBONE AND USE THEREOFGluetacs Therapeutics (Shanghai)06/10/26
-
19KCC2 POTENTIATORS AND USES THEREOFAxonis Therapeutics06/10/26
-
52HETEROARYL DERIVATIVES AS DDRs INHIBITORSChiesi Farmaceutici06/10/26
-
105N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCERWmt Aktiengesellschaft06/10/26
-
50COMPOUND FOR INHIBITING IRAK4 ACTIVITY AND USE THEREOFShenzhen Zhongge Biological Technology06/10/26
-
98MACROCYCLIC IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOFSuzhou Langrui Biopharmaceutical06/10/26
-
167TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERSRegent Of The University Of Michigan06/10/26
-
481,3,4,7-TETRAHYDRO-2H-PYRROLO[3',2':5,6]PYRIDO[2,3-B][1,4]OXAZEPINE BCL-2 INHIBITORSAbbvie06/10/26
-
5Phenalkylamines and methods of treating mood disordersGilgamesh Pharmaceuticals06/08/26
-
81Small molecule modulators of PanKSt. Jude Children''s Research Hospital, Inc.06/08/26
-
289N-(1H-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredientKainos Medicine06/08/26
-
14Spiropiperidine allosteric modulators of nicotinic acetylcholine receptorsMerck Sharp & Dohme06/08/26
-
54Compound having KHK inhibitory effectHangzhou Zhongmeihuadong Pharmaceutical06/08/26
-
46CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOFMaze Therapeutics06/03/26
-
19NAV1.8 INHIBITORWuhan Humanwell Innovative Drug Research and Development Center06/03/26
-
633N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USERepare Therapeutics06/03/26
-
76HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORSUniversity of Texas System06/03/26
-
64NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAMECheckmate Therapeutics06/03/26
-
383PYRROLOPYRIDAZINE VEGFR INHIBITORSMerck Sharp & Dohme06/03/26
-
360SPIROCYCLIC DIHYDROPYRANOPYRIMIDINE KRAS INHIBITORSTreeline Biosciences06/03/26
-
7Pyrrole amide compound and use thereofSunshine Lake Pharma06/01/26
-
192Estrogen-related receptor alpha modulatorsLead Pharma Holding06/01/26
-
148Heteroaromatic derivatives having serotonin receptor binding activityShionogi06/01/26
-
23Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS)Genzyme06/01/26
-
9Enantiomers of a series of antiviral compoundsInnovative Molecules06/01/26
-
82Non-lysosomal glucosylceramidase inhibitors and uses thereofAlectos Therapeutics06/01/26
-
27Heterocyclic compounds for medical treatmentC4 Therapeutics06/01/26
-
192Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereofNurix Therapeutics06/01/26
-
38PI3K INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOFHinova Pharmaceuticals05/29/26
-
19METHODS AND COMPOUNDS FOR INHIBITING MKK7 ENZYMESAxonis Therapeutics05/29/26
-
340BICYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOFDanatlas Pharmaceuticals05/29/26
-
15Organophosphorous Compounds and Uses ThereofJal Therapeutics05/29/26
-
106BICYCLIC-TYPE MAT2A INHIBITOR AND USE THEREOFHaihe Biopharma05/28/26
-
65SUBSTITUTED 3-(l-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE/2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-l,3-DIONE ANALOGS AS MODULATORS OF CEREBLON PROTEINSt. Jude''s Chidren''s Research Hospital, Inc.05/28/26
-
51CDK2 INHIBITORS AND METHODS OF USING THE SAMECedilla Therapeutics05/28/26
-
4DUAL INHIBITORS FOR HDAC3 AND HIV-1 PRPurdue Research Foundation05/28/26
-
109ATM KINASE INHIBITORSEberhard Karls University of TuBingen05/28/26
-
3COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCERKorea Research Institute of Chemical Technology05/28/26
-
15Pharmaceutical composition for treating fatty liver diseaseShionogi05/26/26
-
6Monoamine oxidase B imaging probeTohoku University05/26/26
-
18Antiviral indolinyl compounds and uses thereofGilead Sciences05/26/26
-
22Benzimidazole derivatives and aza-benzimidazole derivatives as Janus kinase 2 inhibitors and uses thereofDana-Farber Cancer Institute05/26/26
-
143,4-dihydroisoquinoline compound and use thereofCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang)05/26/26
-
105Azacycloalkyl carbonyl cyclic amine compoundAlivexis05/26/26
-
411Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYuhan05/26/26
-
182Inhibitors of gas for treating autoinflammatory diseases and cancer metastasisThe Rockefeller University; Memorial Sloan-Kettering Cancer Center05/26/26
-
6Macrocyclic compounds and derivatives as EGFR inhibitorsBoehringer Ingelheim International05/26/26
-
13Thiazololactam compound as ERK inhibitor and use thereofD3 Bio (Wuxi)05/26/26
-
13Cyclophilin inhibitors and uses thereofFarsight Medical Technology (Shanghai)05/26/26
-
123RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORSTrustees of Tufts College05/21/26
-
5COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINEThe Cleveland Clinic Foundation05/21/26
-
140LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOFInsmed05/21/26
-
122CBL-B INHIBITORS AND METHODS OF USES THEREOFInsilico Medicine IP05/21/26
-
12PYRIDAZINE BASED SMALL MOLECULE INHIBITOR OF COGNITIVE IMPAIRMENTColumbia University05/21/26
-
181AZOLE MODULATORS OF CHOLESTEROL BIOSYNTHESIS AND THEIR USE FOR PROMOTING REMYELINATIONGenentech05/21/26
-
12TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIAMemorial Sloan Kettering Cancer Center05/20/26
-
70INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERSUniversity Of Michigan05/20/26
-
326AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOFVentus Therapeutics U.05/20/26
-
1312-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitorsMerck Sharp & Dohme05/19/26
-
65CD38 inhibitorsAstellas Engineered Small Molecules US05/18/26
-
253Inhibitors of antigen presentation by HLA-DRJanssen Pharmaceutica05/18/26
-
3Pyrazolo[1,5-a]pyridine derivatives, preparation method therefor and use thereofShanghai Daidai Investment Consulting05/18/26
-
1Heteroaryl compounds as inhibitors of TYK2/JAK1, composition and application thereofAccro Bioscience (Hk)05/14/26
-
163CHROMAN DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERSUniversity Of Michigan05/13/26
-
5COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINEThe Cleveland Clinic Foundation05/13/26
-
36NOVEL PYRIDAZINESBoehringer Ingelheim International05/13/26
-
111COMPOUND CONTAINING SULFAMIDE STRUCTURE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION AND APPLICATIONNanjing Shuohui Pharmatechnology05/13/26
-
2HETEROCYCLIC COMPOUND CAPABLE OF INHIBITING PRMT5-MTA AND USE THEREOFXizang Haisco Pharmaceutical05/13/26
-
209COMPOUNDS AS MYT1 INHIBITORSWigen Biommedicine Technology (Shanghai)05/13/26
-
12COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORSPrimetime Life Sciences05/13/26
-
3Heterocycle compounds for the treatment of cancerHoffmann-La Roche05/13/26
-
86ENPP1 INHIBITORS IRE Ventures I05/13/26
-
20CYCLIN-DEPENDENT KINASE INHIBITORSNovartis05/13/26
-
90PYRAZOLOPYRIMIDINE PDE9 INHIBITORSMerck Sharp & Dohme05/13/26
-
80COMPOUND FOR REGULATING AND CONTROLLING ACTIVITY OF 15-PGDH AND PREPARATION METHOD THEREFORScinnohub Pharmaceutical05/13/26